Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
ARC Pharmaceuticals, Inc.
Camptothecin-loaded films inhibit formation of adhesions
September 10th, 2003
ARC Pharmaceuticals, Inc., announced that it presented a scientific paper entitled "Camptothecin (CPT) Loaded Films for the Prevention of Surgical Adhesions" at the 6th World Congress on Inflammation held in Vancouver, BC. "The conference offered a distinguished forum to showcase the company's progress in the development of product candidates for the treatment of surgical adhesion disease," commented Jody Cashman, head of preclinical research. ARC presented data that demonstrated camptothecin-loaded films inhibited the formation of adhesions in established preclinical models. Surgical adhesion disease causes dysfunction and pain in millions of...
Source: Biotech Week (2003-09-10)
|
